The past, present, and future of neuromodulation with Dr. Daniel Blumberger

06/26/24 • 26 min

Quick Takes: A podcast by physicians, for physicians

“As far as medical treatments go, ECT is the safest medical procedure in all of medicine.”

Will the stigma around ECT fade? Will ECT simply grow less relevant in the age of ketamine and MST? What’s the future of neuromodulation?
Join Dr. David Gratzer as he speaks to Dr. Daniel Blumberger, scientific director of the Temerty Centre for Therapeutic Brain Intervention and professor at the University of Toronto to find out.

During their discussion, we learn about:

the 20-30 active clinical trials at the Temerty Centre
the impact and efficacy of some of the newer treatments like ketamine, rTMS, and MST
the latest in the literature on ECT and suicide prevention
and that ECT isn’t being replaced any time soon.

THANKS FOR LISTENING!

Quick Takes is a production of the Center for Addiction and Mental Health. You can find links to the relevant content mentioned in the show and accessible transcripts of all the episodes we produce online at CAMH.ca.

Follow CAMH Education on X (formerly known as Twitter) @camhEdu

Follow and subscribe to Reading of the Week where, every week, Dr. David Gratzer reviews research papers from the world of psychiatry.

“As far as medical treatments go, ECT is the safest medical procedure in all of medicine.”

During their discussion, we learn about:

the 20-30 active clinical trials at the Temerty Centre
the impact and efficacy of some of the newer treatments like ketamine, rTMS, and MST
the latest in the literature on ECT and suicide prevention
and that ECT isn’t being replaced any time soon.

THANKS FOR LISTENING!

Follow CAMH Education on X (formerly known as Twitter) @camhEdu

Follow and subscribe to Reading of the Week where, every week, Dr. David Gratzer reviews research papers from the world of psychiatry.

Previous Episode

The new CANMAT depression update with Dr. Raymond Lam

“They really are the most widely used guidelines in the world.”

Much has changed over the past eight years. In 2016, singer Olivia Rodrigo was just starting high school; quarterback Tom Brady seemed ageless; none of us were talking about pandemics. Recently the Canadian Network for Mood and Anxiety Treatments (CANMAT) released its first major depression update in eight years. How has depression management changed, and what does it mean for you and your practice? Join Dr. David Gratzer as he speaks to Dr. Raymond Lam, the co-first author and the executive chair of CANMAT and find out.

In this episode you will learn:

when to recommend exercise (and how to discuss it with your patients)
about the role of pharamacogenetic testing
how to think about neuromodulation
and the reason for the format update to these guidelines.

THANKS FOR LISTENING!

Follow CAMH Education on X (formerly known as Twitter) @camhEdu

Follow and subscribe to Reading of the Week where, every week, Dr. David Gratzer reviews research papers from the world of psychiatry.

Next Episode

[Quick Takes Essentials] Cannabis with Dr. Kevin Hill

Welcome to Quick Takes Essentials our summer series that introduces (or re-introduces) you to episodes from our archives that have focused on important clinical updates and recent big issues in psychiatry.

Take a moment or two this summer to learn something new while enjoying your morning coffee, taking a hike, or relaxing by the campfire.

This selection first aired back in May of 2022 and in it I spoke about cannabis use ("Who should be using cannabis? How should we talk to our patients about it?") with Dr. Kevin Hill of Harvard University.

Please enjoy.

THANKS FOR LISTENING!

Follow CAMH Education on X (formerly known as Twitter) @camhEdu

Follow and subscribe to Reading of the Week where, every week, Dr. David Gratzer reviews research papers from the world of psychiatry.